Figure 3
Figure 3. Endogenous IL-2 from T cells stimulated by CD80/CD86+/+ DCs is required for the differentiation of Foxp3+CD25+CD4+ T cells. (A) As in Figure 2, but Foxp3−CD25−CD4+ T cells from DO11.10 RAG−/− mice were cultured with spleen CD11c+ DCs with peptide plus TGF-β in the presence or absence of blocking anti–IL-2 Ab or control Abs (20 μg/mL). (B) Foxp3−CD25−CD4+ T cells from DO11.10 RAG−/− mice were cultured with spleen CD11c+ DCs (2 × 104) or CD11c− APCs (2 × 105) with indicated dose of peptide in the presence or absence of TGF-β. After day 5, culture supernatants were collected, and the concentration of IL-2 measured by Luminex. (C) CD4+ T cells from Foxp3-IRES-RFP knock-in OVA OTII CD4 transgenic mice (FIR-OTII) were stained with anti-CD4 and CD25 Abs, and Foxp3−CD25−CD4+ T cells were purified by flow cytometry (left). The purity of Foxp3−CD25−CD4+ T cells after sorting was higher than 99.5% (right; gated on CD4+ T cells. (D) The Foxp3−CD25−CD4+ T cells (2 × 104) from FIR-OTII mice were cultured with spleen CD11c+ DCs (2 × 104) for 5 days in the presence of peptide (0.03 μg/mL) with or without TGF-β (2 ng/mL) and/or IL-2 (100 U/mL). Cells were gated on CD4+ T cells. The absolute numbers of Foxp3+CD4+T cells per culture from 4 different experiments with spleen DCs or immature BM-DCs are shown. P value is provided by Student t test. (E) As in panel D, but spleen CD11c+ DCs or immature BM-DCs were prepared from CD80/CD86−/− or wild-type (WT) mice in the presence of peptide with or without TGF-β (2 ng/mL) and/or IL-2 (100 U/mL). Cells were gated on CD4+ T cells. The absolute numbers of Foxp3+CD4+ T cells per culture from 4 different experiments with spleen DCs or immature BM-DCs are shown. P value is provided by Student t test. Data are representative of 2 to 4 independent experiments.

Endogenous IL-2 from T cells stimulated by CD80/CD86+/+ DCs is required for the differentiation of Foxp3+CD25+CD4+ T cells. (A) As in Figure 2, but Foxp3CD25CD4+ T cells from DO11.10 RAG−/− mice were cultured with spleen CD11c+ DCs with peptide plus TGF-β in the presence or absence of blocking anti–IL-2 Ab or control Abs (20 μg/mL). (B) Foxp3CD25CD4+ T cells from DO11.10 RAG−/− mice were cultured with spleen CD11c+ DCs (2 × 104) or CD11c APCs (2 × 105) with indicated dose of peptide in the presence or absence of TGF-β. After day 5, culture supernatants were collected, and the concentration of IL-2 measured by Luminex. (C) CD4+ T cells from Foxp3-IRES-RFP knock-in OVA OTII CD4 transgenic mice (FIR-OTII) were stained with anti-CD4 and CD25 Abs, and Foxp3CD25CD4+ T cells were purified by flow cytometry (left). The purity of Foxp3CD25CD4+ T cells after sorting was higher than 99.5% (right; gated on CD4+ T cells. (D) The Foxp3CD25CD4+ T cells (2 × 104) from FIR-OTII mice were cultured with spleen CD11c+ DCs (2 × 104) for 5 days in the presence of peptide (0.03 μg/mL) with or without TGF-β (2 ng/mL) and/or IL-2 (100 U/mL). Cells were gated on CD4+ T cells. The absolute numbers of Foxp3+CD4+T cells per culture from 4 different experiments with spleen DCs or immature BM-DCs are shown. P value is provided by Student t test. (E) As in panel D, but spleen CD11c+ DCs or immature BM-DCs were prepared from CD80/CD86−/− or wild-type (WT) mice in the presence of peptide with or without TGF-β (2 ng/mL) and/or IL-2 (100 U/mL). Cells were gated on CD4+ T cells. The absolute numbers of Foxp3+CD4+ T cells per culture from 4 different experiments with spleen DCs or immature BM-DCs are shown. P value is provided by Student t test. Data are representative of 2 to 4 independent experiments.

Close Modal

or Create an Account

Close Modal
Close Modal